Indication-Based Formulary Design in CY2020
Beginning in the 2020 contract year (“CY2020”), the Centers for Medicare & Medicaid Services (“CMS”) will permit Part D sponsors to implement indication-based formulary designs that tailor formulary coverage of…
BluePeak AdvisorsSeptember 4, 2018
